DVM MD - InspireMD Executive Affairs
| NSPR Stock | USD 2.69 0.10 3.58% |
Executive
DVM MD is Executive Affairs of InspireMD
| Age | 66 |
| Address | 6303 Waterford District Drive, Miami, FL, United States, 33126 |
| Phone | 888 776 6804 |
| Web | https://www.inspiremd.com |
InspireMD Management Efficiency
The company has return on total asset (ROA) of (0.5816) % which means that it has lost $0.5816 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1395) %, meaning that it created substantial loss on money invested by shareholders. InspireMD's management efficiency ratios could be used to measure how well InspireMD manages its routine affairs as well as how well it operates its assets and liabilities. At this time, InspireMD's Return On Tangible Assets are relatively stable compared to the past year. As of 08/02/2025, Return On Assets is likely to grow to 0.03, though Return On Capital Employed is likely to grow to (0.81). At this time, InspireMD's Return On Assets are relatively stable compared to the past year.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Len Urbas | XTI Aerospace, | N/A | |
| Shirish Tangirala | XTI Aerospace, | N/A | |
| Ryan Bock | SINTX Technologies | N/A | |
| Don Purdy | XTI Aerospace, | N/A | |
| Greg Gironda | Oragenics | N/A | |
| James Xu | Rapid Micro Biosystems | N/A | |
| David OBrien | SINTX Technologies | 59 | |
| Julie Jarvie | Rapid Micro Biosystems | N/A | |
| MD MA | Oragenics | N/A | |
| Captain Zaheer | XTI Aerospace, | N/A | |
| Brooke Martellaro | XTI Aerospace, | N/A | |
| Hugh Roberts | SINTX Technologies | N/A | |
| Sean Wirtjes | Rapid Micro Biosystems | 55 | |
| Nora Brennan | Traws Pharma | 56 | |
| Michael CFA | Rapid Micro Biosystems | N/A | |
| Melanie Figueroa | XTI Aerospace, | N/A | |
| Kristine Williams | Rapid Micro Biosystems | N/A | |
| John Gillings | STRATA Skin Sciences | 49 | |
| Charlie Johnson | XTI Aerospace, | N/A | |
| Kevin Trask | SINTX Technologies | N/A | |
| Jason Lukasek | Rapid Micro Biosystems | N/A | |
Management Performance
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.58 |
InspireMD Leadership Team
Elected by the shareholders, the InspireMD's board of directors comprises two types of representatives: InspireMD inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InspireMD. The board's role is to monitor InspireMD's management team and ensure that shareholders' interests are well served. InspireMD's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InspireMD's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shane Gleason, Chief Officer | ||
| Michael Lawless, Chief Officer | ||
| Roei Samuri, VP Operations | ||
| DVM MD, Executive Affairs | ||
| Craig Shore, CFO, Chief Admin. Officer, Secretary and Treasurer | ||
| Andrea Tommasoli, Chief Officer | ||
| Amir Kohen, Executive Manager | ||
| Marvin Slosman, CEO President | ||
| Pete Ligotti, Executive America | ||
| Sol Barer, Independent Chairman of the Board |
InspireMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InspireMD a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.58 | ||||
| Operating Margin | (7.50) % | ||||
| Current Valuation | 48.84 M | ||||
| Shares Outstanding | 30.64 M | ||||
| Shares Owned By Insiders | 30.14 % | ||||
| Shares Owned By Institutions | 42.21 % | ||||
| Number Of Shares Shorted | 375.9 K | ||||
| Price To Earning | (0.16) X | ||||
| Price To Book | 2.56 X |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.